Neural stem cells (NSCs) are specialized stem cells that have the potential to differentiate into neurons, astrocytes, and oligodendrocytes, the most important types of cells in the nervous system. They are generally found in the subventricular zone (SVZ) and subgranular zone (SGZ) of the hippocampus. These stem cells can self-renew in culture, and when transplanted into the nervous system, they can differentiate into all major cell types of the central nervous system. In recent years, NSCs have become an area of intense interest for medical research, due to their potential to be used in various treatments for diseases of the nervous system, such as spinal cord injury, Huntington’s disease, and stroke. One of the main advantages of using NSCs for therapeutic applications is their ability to respond to environmental cues and differentiate into the appropriate cell types. For example, when transplanted into the brain, NSCs can respond to local cues and differentiate into neurons, which can restore lost function. Other potential applications for NSCs include the production of structures such as blood vessels, which can be used to deliver drugs or oxygen and nutrients to regions of the brain, and the creation of neural networks to explore complex processes. In addition, scientists have begun to explore the potential of using NSCs to treat neurodegenerative diseases, such as Alzheimer’s and Parkinson’s. By identifying, cultivating and transplanting NSCs into areas of the brain affected by these diseases, researchers hope to slow or even reverse the progress of these diseases. Despite the promise of NSCs, there are still many questions to be answered. Research into the mechanisms that regulate NSC development, implantation, and functionality is ongoing, and new techniques are constantly being developed. These studies will help ensure that NSCs are safe and effective for use in clinical settings, and may eventually lead to treatments for a variety of neurological disorders.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States